Exparel 266 MG/20 ML vial 20ML

Ended Awarded Last action

Contract number
SPE2DR26FFCL4
Awardee
Awarding agency
Obligated
$51,346

Award facts

Contract value 100% obligated
$51,346.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 24, 2026, for $51,346.40 (ceiling value) for EXPAREL 266 mg/20 ml vials. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical product supply to Department of Defense healthcare facilities worldwide.

Place of performance is Park Ridge, IL. The order carries an ultimate completion date of April 14, 2026 and is priced on a firm fixed-price basis.

Quick answers

Who was awarded contract SPE2DR26FFCL4?

SPE2DR26FFCL4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 24, 2026.

How much is contract SPE2DR26FFCL4 worth?

The government has obligated $51,346 on SPE2DR26FFCL4.

Is contract SPE2DR26FFCL4 an order under another contract?

Yes. SPE2DR26FFCL4 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.

Was contract SPE2DR26FFCL4 competed?

The extent of competition for SPE2DR26FFCL4 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award